-
1
-
-
0035046477
-
A study of tremor in multiple sclerosis
-
Alusi SH, Worthington J, Glickman S, Bain PG (2001) A study of tremor in multiple sclerosis. Brain 124:720-730 (Pubitemid 32303831)
-
(2001)
Brain
, vol.124
, Issue.4
, pp. 720-730
-
-
Alusi, S.H.1
Worthington, J.2
Glickman, S.3
Bain, P.4
-
3
-
-
39049142995
-
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
-
DOI 10.1056/NEJMoa0706383
-
Hauser SL, Waubant E, Arnold DL et al (2008) B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 358:676-688 (Pubitemid 351240747)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.7
, pp. 676-688
-
-
Hauser, S.L.1
Waubant, E.2
Arnold, D.L.3
Vollmer, T.4
Antel, J.5
Fox, R.J.6
Bar-Or, A.7
Panzara, M.8
Sarkar, N.9
Agarwal, S.10
Langer-Gould, A.11
Smith, C.H.12
-
4
-
-
0141790082
-
Attenuation of cerebellar tremor with implantation of an intrathecal baclofen pump: The role of γ-aminobutyric acidergic pathways - Case report
-
Weiss N, North RB, Ohara S, Lenz FA (2003) Attenuation of cerebellar tremor with implantation of an intrathecal baclofen pump: The role of gamma-aminobutyric acidergic pathways. Case report. J Neurosurg 99:768-771 (Pubitemid 37159054)
-
(2003)
Journal of Neurosurgery
, vol.99
, Issue.4
, pp. 768-771
-
-
Weiss, N.1
North, R.B.2
Ohara, S.3
Lenz, F.A.4
-
5
-
-
0024418209
-
Treatment of cerebellar tremors with carbamazepine: A controlled trial with long-term follow-up
-
Sechi GP, Zuddas M, Piredda M et al (1989) Treatment of cerebellar tremors with carbamazepine: A controlled trial with long term follow up. Neurology 39:1113-1115 (Pubitemid 19217487)
-
(1989)
Neurology
, vol.39
, Issue.8
, pp. 1113-1115
-
-
Sechi, G.P.1
Zuddas, M.2
Piredda, M.3
Agnetti, V.4
Sau, G.5
Piras, M.L.6
Tanca, S.7
Rosati, G.8
-
6
-
-
0021320395
-
Pharmacologic trials in the treatment of cerebellar tremor
-
Koller WC (1984) Pharmacologic trials in the treatment of cerebellar tremor. Arch Neurol 41:280-281 (Pubitemid 14198566)
-
(1984)
Archives of Neurology
, vol.41
, Issue.3
, pp. 280-281
-
-
Koller, W.C.1
-
7
-
-
0030990571
-
Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor
-
Rice GP, Lesaux J, Vandervoort P, Macewan L, Ebers GC (1997) Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor. J Neurol Neurosurg Psychiatry 62:282-284 (Pubitemid 27117260)
-
(1997)
Journal of Neurology Neurosurgery and Psychiatry
, vol.62
, Issue.3
, pp. 282-284
-
-
Rice, G.P.A.1
Lesaux, J.2
Vandervoort, P.3
Macewan, L.4
Ebers, G.C.5
-
8
-
-
77949377354
-
Riluzole in cerebellar ataxia: A randomized, double-blind, placebo-controlled pilot trial
-
Ristori G, Romano S, Visconti A et al (2010) Riluzole in cerebellar ataxia: A randomized, double-blind, placebo-controlled pilot trial. Neurology 74:839-845
-
(2010)
Neurology
, vol.74
, pp. 839-845
-
-
Ristori, G.1
Romano, S.2
Visconti, A.3
-
9
-
-
0035008836
-
The pathophysiology of tremor
-
DOI 10.1002/mus.1063
-
Deuschl G, Raethjen J, Lindemann M, Krack P (2004) The pathophysiology of tremor. Muscle Nerve 24:716-735 (Pubitemid 32476518)
-
(2001)
Muscle and Nerve
, vol.24
, Issue.6
, pp. 716-735
-
-
Deuschl, G.1
Raethjen, J.2
Lindemann, M.3
Krack, P.4
-
10
-
-
0033405293
-
Animal models of tremor
-
DOI 10.1002/1531-8257(199907)14:4<557::AID-MDS1004>3.0.CO;2-G
-
Wilms H, Sievers, Deuschl G et al (1999) Animal models of tremor. Mov Disord 14:557-571 (Pubitemid 30011448)
-
(1999)
Movement Disorders
, vol.14
, Issue.4
, pp. 557-571
-
-
Wilms, H.1
Sievers, J.2
Deuschl, G.3
-
11
-
-
70350786389
-
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): A randomised, double-blind, placebo-controlled trial
-
Comi G, Martinelli V, Rodegher M et al (2009) Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): A randomised, double-blind, placebo-controlled trial. Lancet 374:1503-1511
-
(2009)
Lancet
, vol.374
, pp. 1503-1511
-
-
Comi, G.1
Martinelli, V.2
Rodegher, M.3
-
12
-
-
33749661011
-
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
-
DOI 10.1212/01.wnl.0000237641.33768.8d, PII 0000611420061010000027
-
Kappos L, Polman CH, Freedman MS et al (2006) Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 67:1242-1249 (Pubitemid 44563835)
-
(2006)
Neurology
, vol.67
, Issue.7
, pp. 1242-1249
-
-
Kappos, L.1
Polman, C.H.2
Freedman, M.S.3
Edan, G.4
Hartung, H.P.5
Miller, D.H.6
Montalban, X.7
Barkhof, F.8
Bauer, L.9
Jakobs, P.10
Pohl, C.11
Sandbrink, R.12
-
13
-
-
48849117376
-
B cells and multiple sclerosis
-
Franciotta D, Salyetti M, Lolli F, Serafini B, Aloisi F (2008) B cells and multiple sclerosis. Lancet Neurol 7:852-858
-
(2008)
Lancet Neurol
, vol.7
, pp. 852-858
-
-
Franciotta, D.1
Salyetti, M.2
Lolli, F.3
Serafini, B.4
Aloisi, F.5
-
14
-
-
58149337468
-
Early relapses after the first dose of natalizumab in active multiple sclerosis patients
-
Centonze D, Furlan R, Gasperini C, Salvetti M, Battistini L (2008) Early relapses after the first dose of natalizumab in active multiple sclerosis patients. Mult Scler 14:1137-1138
-
(2008)
Mult Scler
, vol.14
, pp. 1137-1138
-
-
Centonze, D.1
Furlan, R.2
Gasperini, C.3
Salvetti, M.4
Battistini, L.5
|